AI could help decide when You're ready to recover after surgery
NCT ID NCT07406269
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
After gastrointestinal or cancer surgery, it's hard to know when it's safe to start rehabilitation. This study tests an AI tool that analyzes hospital data to predict which patients are ready for early rehab. The tool gives a simple yes/no answer to help doctors decide. The study will enroll 103 adults and track how often patients need extra care within 30 days after early transfer to rehab.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AI-based clinical decision support tool (DESIRE)
- What this could lead to
- If successful, this tool could help doctors make safer, faster decisions about when patients can begin rehabilitation after surgery, potentially reducing hospital stays and complications.
- What could go wrong
- This is an early-stage study with only 103 participants, so results may not apply to all patients. The AI tool is not a replacement for clinical judgment and may not work as expected in different hospital settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Erasmus MC, University Medical Center Rotterdam
Rotterdam, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New platform aims to personalize cancer treatment for GI patients
- Could some GI cancer patients avoid major surgery? new study explores organ preservation
- Could silkworm pupas be the key to fighting muscle loss in cancer survivors?
- New hope for stomach and bowel cancers: experimental drug Rina-S enters Mid-Stage trial
- New hope for stomach cancer: experimental drug BHB810 enters human trials
- Tailored training may boost healthy living in GI cancer survivors